PubMed:16464868
Annnotations
Glycosmos6-MAT
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 69-76 | http://purl.obolibrary.org/obo/MAT_0000081 | denotes | thyroid |
| T2 | 701-708 | http://purl.obolibrary.org/obo/MAT_0000081 | denotes | thyroid |
| T3 | 811-818 | http://purl.obolibrary.org/obo/MAT_0000081 | denotes | thyroid |
| T4 | 889-896 | http://purl.obolibrary.org/obo/MAT_0000081 | denotes | thyroid |
| T5 | 1836-1843 | http://purl.obolibrary.org/obo/MAT_0000081 | denotes | thyroid |
| T6 | 2270-2275 | http://purl.obolibrary.org/obo/MAT_0000488 | denotes | later |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-168 | Sentence | denotes | Co-expression of matriptase and N-acetylglucosaminyltransferase V in thyroid cancer tissues--its possible role in prolonged stability in vivo by aberrant glycosylation. |
| TextSentencer_T2 | 169-391 | Sentence | denotes | UDP-N-acetylglucosamine:alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase (GnT-V) catalyzes the formation of beta-1-6 GlcNAc branches on asparagine-linked oligosaccharides, which is directly linked to tumorigenesis. |
| TextSentencer_T3 | 392-610 | Sentence | denotes | Our recent studies indicate that the secretion of matriptase from cancer cells is increased via the action of GnT-V, as evidenced by the fact that matriptase-bearing beta-1-6 GlcNAc branching is dramatically inhibited. |
| TextSentencer_T4 | 611-826 | Sentence | denotes | In this study, we report on an investigation of the expression of GnT-V and matriptase in thyroid neoplasm tissues to determine the clinical significance on the co-expression of these two proteins in thyroid cancer. |
| TextSentencer_T5 | 827-1162 | Sentence | denotes | Although neither GnT-V nor matriptase was expressed in normal thyroid tissue, positive staining for matriptase and GnT-V was observed in 52/68 and 66/68 cases of papillary carcinoma, 3/23 and 10/23 cases of follicular carcinoma, 5/13 and 9/13 cases of follicular adenoma, and 11/28 and 6/28 cases of anaplastic carcinoma, respectively. |
| TextSentencer_T6 | 1163-1290 | Sentence | denotes | Immunohistochemistry, as well as western blotting, showed that the expression of matriptase paralleled the expression to GnT-V. |
| TextSentencer_T7 | 1291-1549 | Sentence | denotes | However, the expression of matriptase mRNA was not correlated with its protein levels, suggesting that the enhancement in matriptase expression could be regulated by a posttranslational modification such as glycosylation through GnT-V-mediated glycosylation. |
| TextSentencer_T8 | 1550-1805 | Sentence | denotes | In papillary carcinoma, the levels of expression of both GnT-V and matriptase were significantly higher in tumors 1 cm or less in size (microcarcinoma) and in those without poorly differentiated lesions, and the two proteins were significantly correlated. |
| TextSentencer_T9 | 1806-2031 | Sentence | denotes | In contrast, the prognosis of thyroid carcinoma after surgery was neither correlated with the expression GnT-V nor matriptase, because the levels of their expression were quite low in anaplastic (undifferentiated) carcinomas. |
| TextSentencer_T10 | 2032-2294 | Sentence | denotes | These results suggest that prolonged stabilization of matriptase is stabilized by GnT-V-mediated glycosylation in vivo, thus extending its halftime and permitting it to play role in the early phases of papillary carcinoma, but not in its later phase progression. |
| T1 | 0-168 | Sentence | denotes | Co-expression of matriptase and N-acetylglucosaminyltransferase V in thyroid cancer tissues--its possible role in prolonged stability in vivo by aberrant glycosylation. |
| T2 | 169-391 | Sentence | denotes | UDP-N-acetylglucosamine:alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase (GnT-V) catalyzes the formation of beta-1-6 GlcNAc branches on asparagine-linked oligosaccharides, which is directly linked to tumorigenesis. |
| T3 | 392-610 | Sentence | denotes | Our recent studies indicate that the secretion of matriptase from cancer cells is increased via the action of GnT-V, as evidenced by the fact that matriptase-bearing beta-1-6 GlcNAc branching is dramatically inhibited. |
| T4 | 611-826 | Sentence | denotes | In this study, we report on an investigation of the expression of GnT-V and matriptase in thyroid neoplasm tissues to determine the clinical significance on the co-expression of these two proteins in thyroid cancer. |
| T5 | 827-1162 | Sentence | denotes | Although neither GnT-V nor matriptase was expressed in normal thyroid tissue, positive staining for matriptase and GnT-V was observed in 52/68 and 66/68 cases of papillary carcinoma, 3/23 and 10/23 cases of follicular carcinoma, 5/13 and 9/13 cases of follicular adenoma, and 11/28 and 6/28 cases of anaplastic carcinoma, respectively. |
| T6 | 1163-1549 | Sentence | denotes | Immunohistochemistry, as well as western blotting, showed that the expression of matriptase paralleled the expression to GnT-V. However, the expression of matriptase mRNA was not correlated with its protein levels, suggesting that the enhancement in matriptase expression could be regulated by a posttranslational modification such as glycosylation through GnT-V-mediated glycosylation. |
| T7 | 1550-1805 | Sentence | denotes | In papillary carcinoma, the levels of expression of both GnT-V and matriptase were significantly higher in tumors 1 cm or less in size (microcarcinoma) and in those without poorly differentiated lesions, and the two proteins were significantly correlated. |
| T8 | 1806-2031 | Sentence | denotes | In contrast, the prognosis of thyroid carcinoma after surgery was neither correlated with the expression GnT-V nor matriptase, because the levels of their expression were quite low in anaplastic (undifferentiated) carcinomas. |
| T9 | 2032-2294 | Sentence | denotes | These results suggest that prolonged stabilization of matriptase is stabilized by GnT-V-mediated glycosylation in vivo, thus extending its halftime and permitting it to play role in the early phases of papillary carcinoma, but not in its later phase progression. |
| T1 | 0-168 | Sentence | denotes | Co-expression of matriptase and N-acetylglucosaminyltransferase V in thyroid cancer tissues--its possible role in prolonged stability in vivo by aberrant glycosylation. |
| T2 | 169-391 | Sentence | denotes | UDP-N-acetylglucosamine:alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase (GnT-V) catalyzes the formation of beta-1-6 GlcNAc branches on asparagine-linked oligosaccharides, which is directly linked to tumorigenesis. |
| T3 | 392-610 | Sentence | denotes | Our recent studies indicate that the secretion of matriptase from cancer cells is increased via the action of GnT-V, as evidenced by the fact that matriptase-bearing beta-1-6 GlcNAc branching is dramatically inhibited. |
| T4 | 611-826 | Sentence | denotes | In this study, we report on an investigation of the expression of GnT-V and matriptase in thyroid neoplasm tissues to determine the clinical significance on the co-expression of these two proteins in thyroid cancer. |
| T5 | 827-1162 | Sentence | denotes | Although neither GnT-V nor matriptase was expressed in normal thyroid tissue, positive staining for matriptase and GnT-V was observed in 52/68 and 66/68 cases of papillary carcinoma, 3/23 and 10/23 cases of follicular carcinoma, 5/13 and 9/13 cases of follicular adenoma, and 11/28 and 6/28 cases of anaplastic carcinoma, respectively. |
| T6 | 1163-1290 | Sentence | denotes | Immunohistochemistry, as well as western blotting, showed that the expression of matriptase paralleled the expression to GnT-V. |
| T7 | 1291-1549 | Sentence | denotes | However, the expression of matriptase mRNA was not correlated with its protein levels, suggesting that the enhancement in matriptase expression could be regulated by a posttranslational modification such as glycosylation through GnT-V-mediated glycosylation. |
| T8 | 1550-1805 | Sentence | denotes | In papillary carcinoma, the levels of expression of both GnT-V and matriptase were significantly higher in tumors 1 cm or less in size (microcarcinoma) and in those without poorly differentiated lesions, and the two proteins were significantly correlated. |
| T9 | 1806-2031 | Sentence | denotes | In contrast, the prognosis of thyroid carcinoma after surgery was neither correlated with the expression GnT-V nor matriptase, because the levels of their expression were quite low in anaplastic (undifferentiated) carcinomas. |
| T10 | 2032-2294 | Sentence | denotes | These results suggest that prolonged stabilization of matriptase is stabilized by GnT-V-mediated glycosylation in vivo, thus extending its halftime and permitting it to play role in the early phases of papillary carcinoma, but not in its later phase progression. |
GlycoBiology-GDGDB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| _T1 | 193-208 | http://acgg.asia/db/diseases/gdgdb?con_ui=CON00008 | denotes | alpha-mannoside |
ICD10
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 69-76 | http://purl.bioontology.org/ontology/ICD10/E06 | denotes | thyroid |
| T2 | 701-708 | http://purl.bioontology.org/ontology/ICD10/E06 | denotes | thyroid |
| T3 | 811-818 | http://purl.bioontology.org/ontology/ICD10/E06 | denotes | thyroid |
| T4 | 889-896 | http://purl.bioontology.org/ontology/ICD10/E06 | denotes | thyroid |
| T5 | 1836-1843 | http://purl.bioontology.org/ontology/ICD10/E06 | denotes | thyroid |
| T6 | 69-76 | http://purl.bioontology.org/ontology/ICD10/E06.9 | denotes | thyroid |
| T7 | 701-708 | http://purl.bioontology.org/ontology/ICD10/E06.9 | denotes | thyroid |
| T8 | 811-818 | http://purl.bioontology.org/ontology/ICD10/E06.9 | denotes | thyroid |
| T9 | 889-896 | http://purl.bioontology.org/ontology/ICD10/E06.9 | denotes | thyroid |
| T10 | 1836-1843 | http://purl.bioontology.org/ontology/ICD10/E06.9 | denotes | thyroid |
| T11 | 709-717 | http://purl.bioontology.org/ontology/ICD10/C00-D48.9 | denotes | neoplasm |
uniprot-human
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 17-27 | http://www.uniprot.org/uniprot/Q9Y5Y6 | denotes | matriptase |
| T2 | 442-452 | http://www.uniprot.org/uniprot/Q9Y5Y6 | denotes | matriptase |
| T3 | 539-549 | http://www.uniprot.org/uniprot/Q9Y5Y6 | denotes | matriptase |
| T4 | 687-697 | http://www.uniprot.org/uniprot/Q9Y5Y6 | denotes | matriptase |
| T5 | 854-864 | http://www.uniprot.org/uniprot/Q9Y5Y6 | denotes | matriptase |
| T6 | 927-937 | http://www.uniprot.org/uniprot/Q9Y5Y6 | denotes | matriptase |
| T7 | 1244-1254 | http://www.uniprot.org/uniprot/Q9Y5Y6 | denotes | matriptase |
| T8 | 1318-1328 | http://www.uniprot.org/uniprot/Q9Y5Y6 | denotes | matriptase |
| T9 | 1413-1423 | http://www.uniprot.org/uniprot/Q9Y5Y6 | denotes | matriptase |
| T10 | 1617-1627 | http://www.uniprot.org/uniprot/Q9Y5Y6 | denotes | matriptase |
| T11 | 1921-1931 | http://www.uniprot.org/uniprot/Q9Y5Y6 | denotes | matriptase |
| T12 | 2086-2096 | http://www.uniprot.org/uniprot/Q9Y5Y6 | denotes | matriptase |
| T13 | 32-63 | http://www.uniprot.org/uniprot/Q06430 | denotes | N-acetylglucosaminyltransferase |
| T14 | 218-249 | http://www.uniprot.org/uniprot/Q06430 | denotes | N-acetylglucosaminyltransferase |
| T15 | 32-63 | http://www.uniprot.org/uniprot/Q8N0V5 | denotes | N-acetylglucosaminyltransferase |
| T16 | 218-249 | http://www.uniprot.org/uniprot/Q8N0V5 | denotes | N-acetylglucosaminyltransferase |
| T17 | 32-63 | http://www.uniprot.org/uniprot/Q8NFS9 | denotes | N-acetylglucosaminyltransferase |
| T18 | 218-249 | http://www.uniprot.org/uniprot/Q8NFS9 | denotes | N-acetylglucosaminyltransferase |
| T19 | 285-291 | http://www.uniprot.org/uniprot/Q92988 | denotes | beta-1 |
| T20 | 558-564 | http://www.uniprot.org/uniprot/Q92988 | denotes | beta-1 |
uniprot-mouse
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 32-63 | http://www.uniprot.org/uniprot/P97402 | denotes | N-acetylglucosaminyltransferase |
| T2 | 218-249 | http://www.uniprot.org/uniprot/P97402 | denotes | N-acetylglucosaminyltransferase |
GlycoBiology-NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-2 | http://purl.bioontology.org/ontology/NCBITAXON/13893 | denotes | Co |
| T2 | 77-83 | http://purl.bioontology.org/ontology/NCBITAXON/6754 | denotes | cancer |
| T3 | 84-91 | http://purl.bioontology.org/ontology/STY/T024 | denotes | tissues |
| T4 | 209-213 | http://purl.bioontology.org/ontology/NCBITAXON/158455 | denotes | beta |
| T5 | 209-213 | http://purl.bioontology.org/ontology/NCBITAXON/3554 | denotes | beta |
| T6 | 285-289 | http://purl.bioontology.org/ontology/NCBITAXON/3554 | denotes | beta |
| T7 | 285-289 | http://purl.bioontology.org/ontology/NCBITAXON/158455 | denotes | beta |
| T8 | 458-464 | http://purl.bioontology.org/ontology/NCBITAXON/6754 | denotes | cancer |
| T9 | 465-470 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
| T10 | 558-562 | http://purl.bioontology.org/ontology/NCBITAXON/158455 | denotes | beta |
| T11 | 558-562 | http://purl.bioontology.org/ontology/NCBITAXON/3554 | denotes | beta |
| T12 | 718-725 | http://purl.bioontology.org/ontology/STY/T024 | denotes | tissues |
| T13 | 772-774 | http://purl.bioontology.org/ontology/NCBITAXON/13893 | denotes | co |
| T14 | 819-825 | http://purl.bioontology.org/ontology/NCBITAXON/6754 | denotes | cancer |
| T15 | 897-903 | http://purl.bioontology.org/ontology/STY/T024 | denotes | tissue |
| T16 | 989-998 | http://purl.bioontology.org/ontology/NCBITAXON/94546 | denotes | papillary |
| T17 | 999-1008 | http://purl.bioontology.org/ontology/NCBITAXON/166034 | denotes | carcinoma |
| T18 | 1034-1044 | http://purl.bioontology.org/ontology/NCBITAXON/1082341 | denotes | follicular |
| T19 | 1045-1054 | http://purl.bioontology.org/ontology/NCBITAXON/166034 | denotes | carcinoma |
| T20 | 1079-1089 | http://purl.bioontology.org/ontology/NCBITAXON/1082341 | denotes | follicular |
| T21 | 1138-1147 | http://purl.bioontology.org/ontology/NCBITAXON/166034 | denotes | carcinoma |
| T22 | 1255-1265 | http://purl.bioontology.org/ontology/NCBITAXON/871272 | denotes | paralleled |
| T23 | 1553-1562 | http://purl.bioontology.org/ontology/NCBITAXON/94546 | denotes | papillary |
| T24 | 1563-1572 | http://purl.bioontology.org/ontology/NCBITAXON/166034 | denotes | carcinoma |
| T25 | 1844-1853 | http://purl.bioontology.org/ontology/NCBITAXON/166034 | denotes | carcinoma |
| T26 | 2020-2030 | http://purl.bioontology.org/ontology/NCBITAXON/166034 | denotes | carcinomas |
| T27 | 2234-2243 | http://purl.bioontology.org/ontology/NCBITAXON/94546 | denotes | papillary |
| T28 | 2244-2253 | http://purl.bioontology.org/ontology/NCBITAXON/166034 | denotes | carcinoma |
GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 32-65 | http://purl.obolibrary.org/obo/GO_0030144 | denotes | N-acetylglucosaminyltransferase V |
| T2 | 154-167 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
| T3 | 1498-1511 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
| T4 | 1535-1548 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
| T5 | 2129-2142 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
| T6 | 272-281 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | formation |
| T7 | 272-291 | http://purl.obolibrary.org/obo/GO_0050720 | denotes | formation of beta-1 |
| T8 | 429-438 | http://purl.obolibrary.org/obo/GO_0046903 | denotes | secretion |
| T9 | 1444-1453 | http://purl.obolibrary.org/obo/GO_0065007 | denotes | regulated |
| T10 | 1444-1489 | http://purl.obolibrary.org/obo/GO_1901874 | denotes | regulated by a posttranslational modification |
| T11 | 1444-1489 | http://purl.obolibrary.org/obo/GO_1901873 | denotes | regulated by a posttranslational modification |
| T12 | 1444-1489 | http://purl.obolibrary.org/obo/GO_1901875 | denotes | regulated by a posttranslational modification |
| T13 | 1459-1489 | http://purl.obolibrary.org/obo/GO_0043687 | denotes | posttranslational modification |
GO-CC
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 465-470 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
| T2 | 850-853 | http://purl.obolibrary.org/obo/GO_0005731 | denotes | nor |
| T3 | 1917-1920 | http://purl.obolibrary.org/obo/GO_0005731 | denotes | nor |
UBERON-AE
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 84-91 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissues |
| T2 | 718-725 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissues |
| T3 | 897-903 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissue |
NGLY1-deficiency
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-NGLY1-deficiency-B_T1 | 294-300 | chem:24139 | denotes | GlcNAc |
| PD-NGLY1-deficiency-B_T2 | 567-573 | chem:24139 | denotes | GlcNAc |
GlycoBiology-MAT
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 69-76 | http://purl.obolibrary.org/obo/MAT_0000081 | denotes | thyroid |
| T2 | 701-708 | http://purl.obolibrary.org/obo/MAT_0000081 | denotes | thyroid |
| T3 | 811-818 | http://purl.obolibrary.org/obo/MAT_0000081 | denotes | thyroid |
| T4 | 889-896 | http://purl.obolibrary.org/obo/MAT_0000081 | denotes | thyroid |
| T5 | 1836-1843 | http://purl.obolibrary.org/obo/MAT_0000081 | denotes | thyroid |
| T6 | 2270-2275 | http://purl.obolibrary.org/obo/MAT_0000488 | denotes | later |
GlycoBiology-Epitope
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-GlycoEpitope-B_T1 | 964-966 | http://www.glycoepitope.jp/epitopes/AN0785 | denotes | 52 |
| PD-GlycoEpitope-B_T2 | 1106-1108 | http://www.glycoepitope.jp/epitopes/AN0746 | denotes | 28 |
| PD-GlycoEpitope-B_T3 | 1115-1117 | http://www.glycoepitope.jp/epitopes/AN0746 | denotes | 28 |
GlyTouCan-IUPAC
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| GlycanIUPAC_T1 | 294-300 | "http://rdf.glycoinfo.org/glycan/G26693XF" | denotes | GlcNAc |
| GlycanIUPAC_T2 | 567-573 | "http://rdf.glycoinfo.org/glycan/G26693XF" | denotes | GlcNAc |
| GlycanIUPAC_T3 | 294-300 | "http://rdf.glycoinfo.org/glycan/G01864SU" | denotes | GlcNAc |
| GlycanIUPAC_T4 | 567-573 | "http://rdf.glycoinfo.org/glycan/G01864SU" | denotes | GlcNAc |
| GlycanIUPAC_T5 | 294-300 | "http://rdf.glycoinfo.org/glycan/G17605FD" | denotes | GlcNAc |
| GlycanIUPAC_T6 | 567-573 | "http://rdf.glycoinfo.org/glycan/G17605FD" | denotes | GlcNAc |
| GlycanIUPAC_T7 | 294-300 | "http://rdf.glycoinfo.org/glycan/G41950LU" | denotes | GlcNAc |
| GlycanIUPAC_T8 | 567-573 | "http://rdf.glycoinfo.org/glycan/G41950LU" | denotes | GlcNAc |
| GlycanIUPAC_T9 | 294-300 | "http://rdf.glycoinfo.org/glycan/G57195RJ" | denotes | GlcNAc |
| GlycanIUPAC_T10 | 567-573 | "http://rdf.glycoinfo.org/glycan/G57195RJ" | denotes | GlcNAc |
| GlycanIUPAC_T11 | 294-300 | "http://rdf.glycoinfo.org/glycan/G85391SA" | denotes | GlcNAc |
| GlycanIUPAC_T12 | 567-573 | "http://rdf.glycoinfo.org/glycan/G85391SA" | denotes | GlcNAc |
| GlycanIUPAC_T13 | 294-300 | "http://rdf.glycoinfo.org/glycan/G89565QL" | denotes | GlcNAc |
| GlycanIUPAC_T14 | 567-573 | "http://rdf.glycoinfo.org/glycan/G89565QL" | denotes | GlcNAc |
| GlycanIUPAC_T15 | 294-300 | "http://rdf.glycoinfo.org/glycan/G80869MR" | denotes | GlcNAc |
| GlycanIUPAC_T16 | 567-573 | "http://rdf.glycoinfo.org/glycan/G80869MR" | denotes | GlcNAc |
| GlycanIUPAC_T17 | 294-300 | "http://rdf.glycoinfo.org/glycan/G55978NL" | denotes | GlcNAc |
| GlycanIUPAC_T18 | 567-573 | "http://rdf.glycoinfo.org/glycan/G55978NL" | denotes | GlcNAc |
| GlycanIUPAC_T19 | 294-300 | "http://rdf.glycoinfo.org/glycan/G54644LT" | denotes | GlcNAc |
| GlycanIUPAC_T20 | 567-573 | "http://rdf.glycoinfo.org/glycan/G54644LT" | denotes | GlcNAc |
| GlycanIUPAC_T21 | 294-300 | "http://rdf.glycoinfo.org/glycan/G25694UG" | denotes | GlcNAc |
| GlycanIUPAC_T22 | 567-573 | "http://rdf.glycoinfo.org/glycan/G25694UG" | denotes | GlcNAc |
| GlycanIUPAC_T23 | 294-300 | "http://rdf.glycoinfo.org/glycan/G25126RB" | denotes | GlcNAc |
| GlycanIUPAC_T24 | 567-573 | "http://rdf.glycoinfo.org/glycan/G25126RB" | denotes | GlcNAc |
| GlycanIUPAC_T25 | 294-300 | "http://rdf.glycoinfo.org/glycan/G51848AD" | denotes | GlcNAc |
| GlycanIUPAC_T26 | 567-573 | "http://rdf.glycoinfo.org/glycan/G51848AD" | denotes | GlcNAc |
| GlycanIUPAC_T27 | 294-300 | "http://rdf.glycoinfo.org/glycan/G94667GM" | denotes | GlcNAc |
| GlycanIUPAC_T28 | 567-573 | "http://rdf.glycoinfo.org/glycan/G94667GM" | denotes | GlcNAc |
| GlycanIUPAC_T29 | 294-300 | "http://rdf.glycoinfo.org/glycan/G30124BO" | denotes | GlcNAc |
| GlycanIUPAC_T30 | 567-573 | "http://rdf.glycoinfo.org/glycan/G30124BO" | denotes | GlcNAc |
| GlycanIUPAC_T31 | 294-300 | "http://rdf.glycoinfo.org/glycan/G82777EZ" | denotes | GlcNAc |
| GlycanIUPAC_T32 | 567-573 | "http://rdf.glycoinfo.org/glycan/G82777EZ" | denotes | GlcNAc |
| GlycanIUPAC_T33 | 294-300 | "http://rdf.glycoinfo.org/glycan/G10151YZ" | denotes | GlcNAc |
| GlycanIUPAC_T34 | 567-573 | "http://rdf.glycoinfo.org/glycan/G10151YZ" | denotes | GlcNAc |
| GlycanIUPAC_T35 | 294-300 | "http://rdf.glycoinfo.org/glycan/G17585ZM" | denotes | GlcNAc |
| GlycanIUPAC_T36 | 567-573 | "http://rdf.glycoinfo.org/glycan/G17585ZM" | denotes | GlcNAc |
| GlycanIUPAC_T37 | 294-300 | "http://rdf.glycoinfo.org/glycan/G04411CJ" | denotes | GlcNAc |
| GlycanIUPAC_T38 | 567-573 | "http://rdf.glycoinfo.org/glycan/G04411CJ" | denotes | GlcNAc |
| GlycanIUPAC_T39 | 294-300 | "http://rdf.glycoinfo.org/glycan/G38254HJ" | denotes | GlcNAc |
| GlycanIUPAC_T40 | 567-573 | "http://rdf.glycoinfo.org/glycan/G38254HJ" | denotes | GlcNAc |
| GlycanIUPAC_T41 | 294-300 | "http://rdf.glycoinfo.org/glycan/G75188FS" | denotes | GlcNAc |
| GlycanIUPAC_T42 | 567-573 | "http://rdf.glycoinfo.org/glycan/G75188FS" | denotes | GlcNAc |
| GlycanIUPAC_T43 | 294-300 | "http://rdf.glycoinfo.org/glycan/G70374VG" | denotes | GlcNAc |
| GlycanIUPAC_T44 | 567-573 | "http://rdf.glycoinfo.org/glycan/G70374VG" | denotes | GlcNAc |
| GlycanIUPAC_T45 | 294-300 | "http://rdf.glycoinfo.org/glycan/G45176LJ" | denotes | GlcNAc |
| GlycanIUPAC_T46 | 567-573 | "http://rdf.glycoinfo.org/glycan/G45176LJ" | denotes | GlcNAc |
| GlycanIUPAC_T47 | 294-300 | "http://rdf.glycoinfo.org/glycan/G30874VW" | denotes | GlcNAc |
| GlycanIUPAC_T48 | 567-573 | "http://rdf.glycoinfo.org/glycan/G30874VW" | denotes | GlcNAc |
| GlycanIUPAC_T49 | 294-300 | "http://rdf.glycoinfo.org/glycan/G69333MI" | denotes | GlcNAc |
| GlycanIUPAC_T50 | 567-573 | "http://rdf.glycoinfo.org/glycan/G69333MI" | denotes | GlcNAc |
| GlycanIUPAC_T51 | 294-300 | "http://rdf.glycoinfo.org/glycan/G10676XO" | denotes | GlcNAc |
| GlycanIUPAC_T52 | 567-573 | "http://rdf.glycoinfo.org/glycan/G10676XO" | denotes | GlcNAc |
| GlycanIUPAC_T53 | 294-300 | "http://rdf.glycoinfo.org/glycan/G14843DJ" | denotes | GlcNAc |
| GlycanIUPAC_T54 | 567-573 | "http://rdf.glycoinfo.org/glycan/G14843DJ" | denotes | GlcNAc |
| GlycanIUPAC_T55 | 294-300 | "http://rdf.glycoinfo.org/glycan/G47546FR" | denotes | GlcNAc |
| GlycanIUPAC_T56 | 567-573 | "http://rdf.glycoinfo.org/glycan/G47546FR" | denotes | GlcNAc |
| GlycanIUPAC_T57 | 294-300 | "http://rdf.glycoinfo.org/glycan/G73695ZM" | denotes | GlcNAc |
| GlycanIUPAC_T58 | 567-573 | "http://rdf.glycoinfo.org/glycan/G73695ZM" | denotes | GlcNAc |
| GlycanIUPAC_T59 | 294-300 | "http://rdf.glycoinfo.org/glycan/G31923TJ" | denotes | GlcNAc |
| GlycanIUPAC_T60 | 567-573 | "http://rdf.glycoinfo.org/glycan/G31923TJ" | denotes | GlcNAc |
| GlycanIUPAC_T61 | 294-300 | "http://rdf.glycoinfo.org/glycan/G60519EP" | denotes | GlcNAc |
| GlycanIUPAC_T62 | 567-573 | "http://rdf.glycoinfo.org/glycan/G60519EP" | denotes | GlcNAc |
| GlycanIUPAC_T63 | 294-300 | "http://rdf.glycoinfo.org/glycan/G07933IA" | denotes | GlcNAc |
| GlycanIUPAC_T64 | 567-573 | "http://rdf.glycoinfo.org/glycan/G07933IA" | denotes | GlcNAc |
| GlycanIUPAC_T65 | 294-300 | "http://rdf.glycoinfo.org/glycan/G40745NH" | denotes | GlcNAc |
| GlycanIUPAC_T66 | 567-573 | "http://rdf.glycoinfo.org/glycan/G40745NH" | denotes | GlcNAc |
| GlycanIUPAC_T67 | 294-300 | "http://rdf.glycoinfo.org/glycan/G54496YV" | denotes | GlcNAc |
| GlycanIUPAC_T68 | 567-573 | "http://rdf.glycoinfo.org/glycan/G54496YV" | denotes | GlcNAc |
| GlycanIUPAC_T69 | 294-300 | "http://rdf.glycoinfo.org/glycan/G62953SQ" | denotes | GlcNAc |
| GlycanIUPAC_T70 | 567-573 | "http://rdf.glycoinfo.org/glycan/G62953SQ" | denotes | GlcNAc |
| GlycanIUPAC_T71 | 294-300 | "http://rdf.glycoinfo.org/glycan/G70070AY" | denotes | GlcNAc |
| GlycanIUPAC_T72 | 567-573 | "http://rdf.glycoinfo.org/glycan/G70070AY" | denotes | GlcNAc |
| GlycanIUPAC_T73 | 294-300 | "http://rdf.glycoinfo.org/glycan/G78792WC" | denotes | GlcNAc |
| GlycanIUPAC_T74 | 567-573 | "http://rdf.glycoinfo.org/glycan/G78792WC" | denotes | GlcNAc |
| GlycanIUPAC_T75 | 294-300 | "http://rdf.glycoinfo.org/glycan/G25238AV" | denotes | GlcNAc |
| GlycanIUPAC_T76 | 567-573 | "http://rdf.glycoinfo.org/glycan/G25238AV" | denotes | GlcNAc |
| GlycanIUPAC_T77 | 294-300 | "http://rdf.glycoinfo.org/glycan/G40510DP" | denotes | GlcNAc |
| GlycanIUPAC_T78 | 567-573 | "http://rdf.glycoinfo.org/glycan/G40510DP" | denotes | GlcNAc |
| GlycanIUPAC_T79 | 294-300 | "http://rdf.glycoinfo.org/glycan/G61120TK" | denotes | GlcNAc |
| GlycanIUPAC_T80 | 567-573 | "http://rdf.glycoinfo.org/glycan/G61120TK" | denotes | GlcNAc |
| GlycanIUPAC_T81 | 294-300 | "http://rdf.glycoinfo.org/glycan/G41342KV" | denotes | GlcNAc |
| GlycanIUPAC_T82 | 567-573 | "http://rdf.glycoinfo.org/glycan/G41342KV" | denotes | GlcNAc |
| GlycanIUPAC_T83 | 294-300 | "http://rdf.glycoinfo.org/glycan/G90703NA" | denotes | GlcNAc |
| GlycanIUPAC_T84 | 567-573 | "http://rdf.glycoinfo.org/glycan/G90703NA" | denotes | GlcNAc |
| GlycanIUPAC_T85 | 294-300 | "http://rdf.glycoinfo.org/glycan/G01591HR" | denotes | GlcNAc |
| GlycanIUPAC_T86 | 567-573 | "http://rdf.glycoinfo.org/glycan/G01591HR" | denotes | GlcNAc |
| GlycanIUPAC_T87 | 294-300 | "http://rdf.glycoinfo.org/glycan/G56520XN" | denotes | GlcNAc |
| GlycanIUPAC_T88 | 567-573 | "http://rdf.glycoinfo.org/glycan/G56520XN" | denotes | GlcNAc |
| GlycanIUPAC_T89 | 294-300 | "http://rdf.glycoinfo.org/glycan/G81830JX" | denotes | GlcNAc |
| GlycanIUPAC_T90 | 567-573 | "http://rdf.glycoinfo.org/glycan/G81830JX" | denotes | GlcNAc |
performance-test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 84-91 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissues |
| PD-UBERON-AE-B_T2 | 718-725 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissues |
| PD-UBERON-AE-B_T3 | 897-903 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissue |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 69-83 | Disease | denotes | thyroid cancer | http://purl.obolibrary.org/obo/MONDO_0002108|http://purl.obolibrary.org/obo/MONDO_0015075 |
| T3 | 458-464 | Disease | denotes | cancer | http://purl.obolibrary.org/obo/MONDO_0004992 |
| T4 | 701-717 | Disease | denotes | thyroid neoplasm | http://purl.obolibrary.org/obo/MONDO_0002108|http://purl.obolibrary.org/obo/MONDO_0015074 |
| T6 | 811-825 | Disease | denotes | thyroid cancer | http://purl.obolibrary.org/obo/MONDO_0002108|http://purl.obolibrary.org/obo/MONDO_0015075 |
| T8 | 989-1008 | Disease | denotes | papillary carcinoma | http://purl.obolibrary.org/obo/MONDO_0006509 |
| T9 | 1034-1054 | Disease | denotes | follicular carcinoma | http://purl.obolibrary.org/obo/MONDO_0005034 |
| T10 | 1079-1097 | Disease | denotes | follicular adenoma | http://purl.obolibrary.org/obo/MONDO_0005032 |
| T11 | 1127-1147 | Disease | denotes | anaplastic carcinoma | http://purl.obolibrary.org/obo/MONDO_0005617 |
| T12 | 1553-1572 | Disease | denotes | papillary carcinoma | http://purl.obolibrary.org/obo/MONDO_0006509 |
| T13 | 1657-1663 | Disease | denotes | tumors | http://purl.obolibrary.org/obo/MONDO_0005070 |
| T14 | 1836-1853 | Disease | denotes | thyroid carcinoma | http://purl.obolibrary.org/obo/MONDO_0015075 |
| T15 | 2001-2030 | Disease | denotes | (undifferentiated) carcinomas | http://purl.obolibrary.org/obo/MONDO_0005617 |
| T16 | 2234-2253 | Disease | denotes | papillary carcinoma | http://purl.obolibrary.org/obo/MONDO_0006509 |
Anatomy-MAT
| Id | Subject | Object | Predicate | Lexical cue | mat_id |
|---|---|---|---|---|---|
| T1 | 69-76 | Body_part | denotes | thyroid | http://purl.obolibrary.org/obo/MAT_0000081 |
| T2 | 701-708 | Body_part | denotes | thyroid | http://purl.obolibrary.org/obo/MAT_0000081 |
| T3 | 811-818 | Body_part | denotes | thyroid | http://purl.obolibrary.org/obo/MAT_0000081 |
| T4 | 889-896 | Body_part | denotes | thyroid | http://purl.obolibrary.org/obo/MAT_0000081 |
| T5 | 1836-1843 | Body_part | denotes | thyroid | http://purl.obolibrary.org/obo/MAT_0000081 |
| T6 | 2270-2275 | Body_part | denotes | later | http://purl.obolibrary.org/obo/MAT_0000488 |
HP-phenotype
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 77-83 | Phenotype | denotes | cancer | HP:0002664 |
| T2 | 458-464 | Phenotype | denotes | cancer | HP:0002664 |
| T3 | 709-717 | Phenotype | denotes | neoplasm | HP:0002664 |
| T4 | 819-825 | Phenotype | denotes | cancer | HP:0002664 |
| T5 | 999-1008 | Phenotype | denotes | carcinoma | HP:0030731 |
| T6 | 1045-1054 | Phenotype | denotes | carcinoma | HP:0030731 |
| T7 | 1138-1147 | Phenotype | denotes | carcinoma | HP:0030731 |
| T8 | 1563-1572 | Phenotype | denotes | carcinoma | HP:0030731 |
| T9 | 1836-1853 | Phenotype | denotes | thyroid carcinoma | HP:0002890 |
| T10 | 2020-2030 | Phenotype | denotes | carcinomas | HP:0030731 |
| T11 | 2244-2253 | Phenotype | denotes | carcinoma | HP:0030731 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 69-76 | Body_part | denotes | thyroid | http://purl.obolibrary.org/obo/UBERON_0002046 |
| T2 | 701-708 | Body_part | denotes | thyroid | http://purl.obolibrary.org/obo/UBERON_0002046 |
| T3 | 811-818 | Body_part | denotes | thyroid | http://purl.obolibrary.org/obo/UBERON_0002046 |
| T4 | 889-896 | Body_part | denotes | thyroid | http://purl.obolibrary.org/obo/UBERON_0002046 |
| T5 | 897-903 | Body_part | denotes | tissue | http://purl.obolibrary.org/obo/UBERON_0000479 |
| T6 | 1836-1843 | Body_part | denotes | thyroid | http://purl.obolibrary.org/obo/UBERON_0002046 |
CL-cell
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 458-470 | Cell | denotes | cancer cells | http://purl.obolibrary.org/obo/CL:0001064 |